Marsh & McLennan Companies: BofA Global Research cuts price objective to $177 from $182
MRSH•BofA Global Research cut its price objective for Marsh & McLennan Companies to $177 from $182.
Related News
Press digest: Canada - October 12
USO•
Weave goes live with Synchrony’s CareCredit integration for patient financing
WEAV•
BofA double-upgrades Salesforce to 'buy'; shares rise
CRM•
Bausch Health pilot study shows standardized cirrhosis pathway lifts guideline adherence in community GI practices
BHC•
Shoulder Innovations, Inc.: BTIG raises target price to $27 from $26
SI•